SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
-2.29%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$592M
AUM Growth
+$592M
(-4.9%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
59.76%
Holding
37
New
3
Increased
13
Reduced
9
Closed
3
Top Buys
| 1 |
Eli Lilly
LLY
|
$17M |
| 2 |
United Therapeutics
UTHR
|
$11.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$8.81M |
| 4 |
Elanco Animal Health
ELAN
|
$6.17M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.05M |
Top Sells
| 1 |
Biogen
BIIB
|
$14.6M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
$12.9M |
| 3 |
Abbott
ABT
|
$12.6M |
| 4 |
Viatris
VTRS
|
$9.61M |
| 5 |
CVS Health
CVS
|
$9.58M |
Sector Composition
| 1 | Healthcare | 99.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
26
DELISTED
Patterson Companies, Inc.
PDCO
| $8.36M | 1.41% |
469,255
| – | – |
|
27
Ionis Pharmaceuticals
IONS
$6.79B
| $7.88M | 1.33% |
131,514
| – | – |
|
28
Alnylam Pharmaceuticals
ALNY
$58.5B
| $7.79M | 1.32% |
96,900
+25,000
| +35% | +$2.01M |
|
29
Ultragenyx Pharmaceutical
RARE
$2.89B
| $7.4M | 1.25% |
172,978
+93,325
| +117% | +$3.99M |
|
30
PTC Therapeutics
PTCT
$3.92B
| $4.11M | 0.69% |
121,402
-108,096
| -47% | -$3.66M |
|
|
PTLA
31
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.38M | 0.57% |
125,925
-78,000
| -38% | -$2.09M |
|
32
Agios Pharmaceuticals
AGIO
$2.19B
| $3.33M | 0.56% |
102,913
| – | – |
|
33
Sangamo Therapeutics
SGMO
$157M
| $2.28M | 0.38% |
251,698
| – | – |
|
|
CLVS
34
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.7M | 0.29% |
431,425
| – | – |
|
|
35
CVS Health
CVS
$92.8B
| – | – |
-175,743
| Closed | -$9.58M |
|
36
McKesson
MCK
$85.4B
| – | – |
-44,175
| Closed | -$5.94M |
|
|
37
Viatris
VTRS
$12.3B
| – | – |
-504,592
| Closed | -$9.61M |
|